Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Oct 15, 2019 9:07pm

599 Views

Post# 30234207

RE:RE:RE:more from Twitter

Thor6570 wrote:
Maybe some of our American friends can tweet link to CNN doctor Sanje Gupta. I am not a Twitter user due to some of the costic users.

Very bold statement as they are already saying that TLD 1433 will displace BCG in early bladder cancer. This has enormous potential. 21 cents is a joke, as is $0.47. You can bet Mackie will be revising their target as we start gaining some sanity again.
Macer

Bullboard Posts

Debt-free cannabis company set for next stage of growth